PMCT
PharmaCountry
+ Create
EN
Demands
Home
Products
Services
Jobs
Seekers
Home
/
Insights
/
Regulatory Updates
Regulatory Updates
FDA, EMA, TGA and global regulatory developments
#DOXERCALCIFEROL
×
Daily News
Analysis
Research & Reports
Regulatory Updates
UPDATED
Regulatory Updates
Sep 11, 2026
•
1 min read
FDA Approves Lupin’s DOXERCALCIFEROL Injection (ANDA210801)
The FDA approved Lupin’s injectable DOXERCALCIFEROL (4 mcg/2 ml) under ANDA210801; the product is listed as discontinued.